2011 Annual Meeting | Neurodevelopmental Disabilities Across the Lifespan
| 01:00 PM - 01:15 PM | Prevalence and Epidemiology of the Neurodevelopmental Disabilities Max Wiznitzer, MD, FAAN | |
| 01:15 PM - 02:05 PM | Neurodevelopmental Impact of Prematurity Laura R. Ment, MD | |
| 02:05 PM - 03:00 PM | Age Specific Neurodevelopmental Phenotypes of Selected Chromosomal Disorders: What the Neurologist Needs to Know Andrea L. Gropman, MD, FAAN | |
| 03:00 PM - 03:15 PM | Break | |
| 03:15 PM - 04:05 PM | Autism Spectrum Disorders-Diagnosis and Treatment Deborah Hirtz, MD, FAAN | |
| 04:05 PM - 05:00 PM | Use of Complementary and Alternative Medicine in the Neurodevelopmental Disabilities Max Wiznitzer, MD, FAAN | 
| Deborah Hirtz, MD, FAAN | No disclosure on file | 
| Laura R. Ment, MD | No disclosure on file | 
| Max Wiznitzer, MD, FAAN | Dr. Wiznitzer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Department of Health and Human Services - Vaccine Injury Compensation Program. Dr. Wiznitzer has a non-compensated relationship as a Board of Directors with CHADD that is relevant to AAN interests or activities. | 
| Andrea L. Gropman, MD, FAAN | Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Mirica. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health. The institution of Dr. Gropman has received research support from O'Malley Family Foundation. |